{
    "title": "AbbVie sets aside $2 bln to settle U.S. opioid claims",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-11061733/AbbVie-sets-aside-2-bln-settle-U-S-opioid-claims.html",
    "date": "2022-07-29",
    "keywords": [
        "drug",
        "settlement",
        "charge",
        "company",
        "deal",
        "demand",
        "skyrizi",
        "inc",
        "unit",
        "marketing",
        "opioid",
        "state",
        "country",
        "litigation",
        "quarter",
        "painkiller",
        "business",
        "abbvie",
        "friday",
        "rise",
        "profit",
        "share",
        "psoriasis",
        "botox",
        "injection",
        "market",
        "arthritis",
        "treatment",
        "rinvoq",
        "loss",
        "patent",
        "exclusivity",
        "humira",
        "rinvoqs",
        "cancer",
        "imbruvica",
        "venclexta",
        "reporting",
        "bengaluru",
        "brendan",
        "pierson",
        "york",
        "editing",
        "aditya",
        "soni"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}